Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue November 2015
 •  Unilever Sells Brands to Strength of Nature  •  SESA Names New Tech Manager  •  Alterna Names New Education Director  •  Beauty App Links Up With Toys 'R' Us  •  P&G Rewrites Holiday Classic for Febreze

Dermatology Drug Market To Grow 8% a Year to 2008

Published November 22, 2005
Related Searches: treatment dermatology men food
Post a comment
The Dermatology Drug market will grow 8% a year to 2008, led by demand for psoriasis treatments, according to the “Dermatology pipeline analysis: a market with room to grow” report by Decision Resources (DR), Waltham, MA. This is largely due to the Food and Drug Administration’s approval of Enbrel, an Amgen-based treatment for adults with moderate-to-severe chronic plaque psoriasis. Medications for atopic dermatitis will also increase, but uticario medications will decline.

blog comments powered by Disqus